DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026)
DiaMedica Therapeutics (DMAC) reported Operating Leases of $200000.0 for Q1 2026, down 31.97% on a YoY basis from $294000.0 in Q1 2025, and up 61.29% quarter-over-quarter from $124000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Operating Leases (2019 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Operating Leases for 8 years, with the latest figure at $200000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 31.97% year-over-year to $200000.0; the trailing twelve-month figure through Mar 2026 stood at $200000.0 (down 31.97% YoY), and the FY2025 full-year result was $124000.0, down 44.89% from the prior year.
- Operating Leases for Q1 2026 stood at $200000.0, up from $124000.0 in the prior quarter.
- The five-year high for Operating Leases was $459000.0 in Q3 2022, with the low at $28000.0 in Q1 2022.
- Historically, Operating Leases has averaged $290235.3 across 5 years, with a median of $294000.0 in 2024.
- The largest YoY upside for Operating Leases was 13100.0% in 2022 against a maximum downside of 69.23% in 2022.
- DiaMedica Therapeutics' Operating Leases stood at $396000.0 in 2022, then fell by 20.2% to $316000.0 in 2023, then fell by 28.8% to $225000.0 in 2024, then sank by 44.89% to $124000.0 in 2025, then soared by 61.29% to $200000.0 in 2026.
- The last three Operating Leases figures came in at $200000.0 (Q1 2026), $124000.0 (Q4 2025), and $150000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2025 | 124,000.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 176,000.00 |
| Mar 31, 2025 | 294,000.00 |
| Dec 31, 2024 | 225,000.00 |
| Sep 30, 2024 | 249,000.00 |
| Jun 30, 2024 | 357,000.00 |
| Mar 31, 2024 | 294,000.00 |
| Dec 31, 2023 | 316,000.00 |
| Sep 30, 2023 | 337,000.00 |
| Jun 30, 2023 | 433,000.00 |
| Mar 31, 2023 | 450,000.00 |
| Dec 31, 2022 | 396,000.00 |
| Sep 30, 2022 | 459,000.00 |
| Jun 30, 2022 | 446,000.00 |
| Mar 31, 2022 | 28,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 75,000.00 |